Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
NeoVac Logo
NeoVac Growth Score
29
CB Rank
465707
Heat Score
52
NeoVac is creating a revolutionary, unique and proprietary next generation lipid nanoparticles to enable RNA vaccines for various diseases.
Founded
obfuscation
PrivateSeed Didcot, Oxfordshire, United Kingdom11-50 www.neovac.co.uk/
Biotechnology
Overview

NeoVac
Growth Score
29
Heat Score
52

Growth Score29
-2 pts
in past quarter
Heat Score 52
-19 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About NeoVac

CB Rank
465707
NeoVac is creating a revolutionary, unique and proprietary next generation lipid nanoparticles to enable RNA vaccines for various diseases.
Founded
obfuscation
PrivateSeed Didcot, Oxfordshire, United Kingdom11-50 www.neovac.co.uk/
Biotechnology

Funding Rounds

Seed
OBF
in
obfuscation

Key People

Details

Operating Status Active
Company Type For Profit
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Next Generation Lipid Nanoparticles (LNP) Platform
A proprietary lipid nanoparticle technology designed to deliver mRNA vaccines and treatments for various diseases.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - NeoVac Logo
Seed Round - NeoVac
1
obfuscation
— Seed
obfuscation
Seed Round - NeoVac Logo
Seed Round - NeoVac
1
obfuscation
— Seed
obfuscation
Seed Round - NeoVac Logo
Seed Round - NeoVac
1
obfuscation
— Seed
obfuscation
Seed Round - NeoVac Logo
Seed Round - NeoVac
1
obfuscation
— Seed
obfuscation
Seed Round - NeoVac Logo
Seed Round - NeoVac
1
obfuscation
— Seed

Funding Rounds

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - NeoVac Logo
Seed Round - NeoVac
1
obfuscation
— Seed
obfuscation
Seed Round - NeoVac Logo
Seed Round - NeoVac
1
obfuscation
— Seed
obfuscation
Seed Round - NeoVac Logo
Seed Round - NeoVac
1
obfuscation
— Seed
obfuscation
Seed Round - NeoVac Logo
Seed Round - NeoVac
1
obfuscation
— Seed
obfuscation
Seed Round - NeoVac Logo
Seed Round - NeoVac
1
obfuscation
— Seed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 1 Contacts 12

Employee Profiles

News

News and Press

News•Sep 19, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Sep 16, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

106
-87.04%
 in past month

IT Spend

$144.2KThis year, NeoVac is projected to spend $144.2K on IT, according to Aberdeen.

Active Website Tech Count

2NeoVac is actively using 2 technologies for its website, according to BuiltWith. These include Common Crawl and  CommonCrawl Top 50m.

Total IP

4The intellectual property of NeoVac includes 4 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is NeoVac's headquarters? NeoVac is located in Didcot, Oxfordshire, United Kingdom.Who invested in NeoVac? NeoVac is funded by Future Planet Capital.When was the last funding round for NeoVac? NeoVac closed its last funding round on
obfuscation
from a Seed round.Who are NeoVac's competitors? Alternatives and possible competitors to NeoVac may include Moderna, BioNTech, and  Precision NanoSystem.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8fe006b 1)
|